amiodarone has been researched along with vernakalant in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 23 (82.14) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Camm, AJ; Savelieva, I | 1 |
| Conway, E; Kowey, PR; Musco, S | 1 |
| Ehrlich, JR; Nattel, S | 1 |
| DiMarco, JP; Mason, PK | 1 |
| Dobrev, D; Nattel, S | 1 |
| Eschenhagen, T; Hirt, MN | 1 |
| Kuz'min, VS; Rozenshtraukh, LV | 1 |
| Huikuri, HV; Raatikainen, MJ | 1 |
| Brachmann, J; Ritscher, G; Simon Demel, K; Simon, H; Turschner, O | 1 |
| Abdollah, H; Baranchuk, AM; Michael, KA; Miranda, RI; Redfearn, DP; Simpson, CS | 1 |
| Burkhardt, JD; Di Biase, L; Natale, A; Pelargonio, G; Santangeli, P | 1 |
| Beatch, G; Camm, AJ; Capucci, A; Hohnloser, SH; Mangal, B; Torp-Pedersen, C; Van Gelder, IC | 1 |
| Capucci, A; Marinelli, A | 1 |
| Calkins, H; Lim, SH; Sinha, SK | 1 |
| Capucci, A; Di Pasquale, G | 1 |
| Saklani, P; Skanes, A | 1 |
| Botto, GL; Campana, C; Mariconti, B; Pentimalli, F; Russo, G | 1 |
| Van Wagoner, DR | 1 |
| Alves de Lima, A; Conde, D; Costabel, JP | 1 |
| Conde, D | 1 |
| Ravens, U | 1 |
| Reiffel, JA | 2 |
| Bollmann, A; Hindricks, G; John, S; Kosiuk, J; Müssigbrodt, A; Richter, S | 1 |
| Capucci, A; Guerra, F; Matassini, MV; Scappini, L; Urbinati, A | 1 |
| Chiba, T; Kondo, N; Takahara, A | 1 |
| Bove, T; Cilenti, F; Copetti, R; Cristiani, L; Guglielmo, N; Orso, D; Santangelo, S | 1 |
16 review(s) available for amiodarone and vernakalant
| Article | Year |
|---|---|
New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
Topics: Amiodarone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anisoles; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazolidines; Piperazines; Pyrrolidines | 2008 |
Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Dronedarone; Humans; Pyrrolidines | 2009 |
New pharmacological agents for arrhythmias.
Topics: Acetanilides; Adenosine A1 Receptor Agonists; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Benzofurans; Clinical Trials as Topic; Dronedarone; Humans; Ivabradine; Piperazines; Pyrrolidines; Ranolazine | 2009 |
New antiarrhythmic drugs for treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Dronedarone; Humans; Piperazines; Pyrrolidines; Ranolazine; Renin-Angiotensin System | 2010 |
[Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm].
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Heart Rate; Heart Ventricles; Humans; Membrane Potentials; Pyrrolidines | 2010 |
[Ionic mechanisms of action of class III antiarrhythmic drugs].
Topics: Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dronedarone; Electric Impedance; Electrocardiography; Heart Atria; Heart Rate; Heart Ventricles; Humans; Ion Channels; Long QT Syndrome; Mutation; Myocytes, Cardiac; Pyrrolidines; Rabbits; Rats | 2010 |
[New developments in the antiarrhythmic therapy of atrial fibrillation].
Topics: Acetanilides; Aged; Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug-Related Side Effects and Adverse Reactions; Drugs, Investigational; Electrocardiography; Heart Atria; Heart Failure; Heart Ventricles; Humans; Piperazines; Potassium Channels; Pyrrolidines; Ranolazine; Sodium Channels; Stroke | 2010 |
Advances in the treatment of atrial fibrillation.
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Dronedarone; Drug Therapy, Combination; Heart Conduction System; Humans; Pyrrolidines; Treatment Outcome | 2010 |
The pharmaceutical pipeline for atrial fibrillation.
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Atrial Fibrillation; Clinical Trials as Topic; Dronedarone; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrrolidines; Renin-Angiotensin System; Treatment Outcome | 2011 |
Antiarrhythmic drugs for atrial fibrillation.
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Heart Rate; Humans; Pyrrolidines; Stroke; Treatment Outcome | 2011 |
[Update on current care guidelines: atrial fibrillation].
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Dronedarone; Finland; Humans; Patient Selection; Practice Guidelines as Topic; Pyrrolidines | 2011 |
Update on the management of atrial fibrillation: anticoagulation and medical therapy.
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dronedarone; Drug Approval; Evidence-Based Medicine; Factor Xa Inhibitors; Female; Humans; Infusions, Intravenous; Male; Practice Guidelines as Topic; Pyridines; Pyrrolidines; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2011 |
Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left | 2012 |
[New developments in the antiarrhythmic therapy of atrial fibrillation].
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Dronedarone; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Piperazines; Pyrrolidines; Ranolazine; Sodium Channel Blockers; Treatment Outcome | 2014 |
New anthyarrhythmic drugs for atrial fibrillation.
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Pyrrolidines; Ranolazine | 2015 |
Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Network Meta-Analysis; Quinidine; Randomized Controlled Trials as Topic; Ranolazine; Systematic Reviews as Topic; Verapamil | 2023 |
1 trial(s) available for amiodarone and vernakalant
| Article | Year |
|---|---|
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.
Topics: Acute Disease; Aged; Amiodarone; Anisoles; Atrial Fibrillation; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyrrolidines; Treatment Outcome | 2011 |
11 other study(ies) available for amiodarone and vernakalant
| Article | Year |
|---|---|
New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Dronedarone; Humans; Pyrrolidines | 2008 |
[New antiarrhythmic drugs for treatment of atrial fibrillation].
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug Design; Electric Countershock; Humans; Membrane Transport Modulators; Pyrrolidines | 2010 |
[The AVRO study].
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Pyrrolidines; Randomized Controlled Trials as Topic | 2011 |
[New antiarrhythmic drugs for the treatment of atrial fibrillation].
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Pyrrolidines | 2012 |
Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?
Topics: Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Female; Heart Atria; Humans; Male; Pyrrolidines; Sodium Channel Blockers | 2013 |
Recent-onset atrial fibrillation in patients with left ventricular dysfunction: amiodarone or vernakalant?
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Decision Making; Heart Rate; Humans; Infusions, Intravenous; Pyrrolidines; Ventricular Dysfunction, Left | 2013 |
Conversion of recent onset atrial fibrillation: which drug is faster?
Topics: Administration, Oral; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Injections, Intravenous; Propafenone; Pyrrolidines; Time Factors | 2013 |
Editorial: advances in the therapy of atrial fibrillation: incrementally progressive but not without missteps.
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Dronedarone; Drug Design; Humans; Pyrrolidines | 2014 |
Are we at the goal line with the novel oral anticoagulants and have we reached the end of the line for dronedarone and vernakalant--or is there more to come?
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Dronedarone; Embolism; Humans; Pyrrolidines; Stroke | 2014 |
Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.
Topics: Aged; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Premedication; Pyrrolidines; Treatment Failure; Treatment Outcome | 2016 |
Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits.
Topics: Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Bepridil; Cardiac Pacing, Artificial; Disease Models, Animal; Infusions, Intravenous; Male; Pyrrolidines; Rabbits; Sotalol | 2016 |